You are here

breast cancer

Pfizer's new drug data in breast cancer draws muted response

Pharmaphorum

Tue, 03/11/25 - 11:04 am

clinical trials

AstraZeneca therapy improves survival in late-stage breast cancer trial

MSN/Reuters

Wed, 02/26/25 - 11:04 am

clinical trials

Novartis to Make Super Bowl 2025 Debut with Breast Cancer Commercial

Xtalks

Thu, 01/30/25 - 11:24 pm

DTC advertising

Roche's breast cancer entrant Itovebi bolsters clinical profile with overall survival win

Fierce Pharma

Tue, 01/28/25 - 09:37 pm

clinical trials

Bayer makes hot flash splash, hitting phase 3 breast cancer goal to steal march on Astellas

Fierce Biotech

Thu, 01/9/25 - 11:11 am

clinical trials

Pfizer's Ibrance improves survival in new breast cancer indication

BioSpace

Thu, 12/12/24 - 11:35 am

clinical trials

Lynparza boosts long-term survival in early breast cancer

Pharmaphorum

Thu, 12/12/24 - 11:29 am

BioNTech's overall survival data show promise of potential Keytruda killer in breast cancer

Fierce Biotech

Tue, 12/10/24 - 11:42 am

clinical trials

Olema stock surges on Novartis deal and $250M private placement

Investing.com

Mon, 12/2/24 - 11:09 am

Relief for AZ as Truqap hits the spot in prostate cancer

Pharmaphorum

Mon, 11/25/24 - 09:23 am

clinical trials

Myriad signs five partnerships to study MRD testing in breast cancer

Clinical Trials Arena

Wed, 10/9/24 - 10:13 am

Myriad Genetics

Roche CEO: breast cancer pill could enter $12 bln market if trials succeed

Reuters

Wed, 10/9/24 - 09:44 am

clinical trials

Oncolytics targets accelerated approval for oncolytic virus therapy

Clinical Trials Arena

Tue, 10/8/24 - 09:50 am

oncolytic viruses

clinical trials

AstraZeneca's experimental drug disappoints in breast cancer survival trial

Reuters

Mon, 09/23/24 - 11:29 am

clinical trials

Daiichi Sankyo launches first DTC ad for Enhertu, representing shift toward patient-centric oncology campaigns

Medical Marketing and Media

Sun, 09/22/24 - 09:46 pm

metastatic breast cancer

Novartis heaps pressure on Lilly with broad FDA approval for Kisqali in early breast cancer

Fierce Pharma

Tue, 09/17/24 - 11:08 pm

ESMO-2024: Enhertu to eclipse the standard of care in HER2+ breast cancer with brain metastases

Clinical Trials Arena

Tue, 09/17/24 - 11:20 am

metastatic breast cancer

clinical trials

Novartis’ breast cancer trial of Kisqali reveals 28.5% risk reduction

Clinical Trials Arena

Mon, 09/16/24 - 10:56 am

clinical trials

Relay races toward pivotal trial as breast cancer data tee up clash with AstraZeneca's Truqap

Fierce Biotech

Mon, 09/9/24 - 11:01 am

Relay Therapeutics

clinical trials

Avenzo and Gilead partner for breast cancer combination regimen trial

Clinical Trials Arena

Wed, 09/4/24 - 11:39 am

Avenzo Therapeutics

Gilead Sciences

clinical trials

Pages